Plain-English translation of NCT07119229 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Implantable Artificial Bronchus (IAB), a polymer-based implant that doctors place directly into diseased areas of the lungs to help people with severe emphysema. The device is designed to restore function to damaged lung tissue and improve breathing. This is an early-stage study to see if the implant is safe and works as hoped.
Severe emphysema causes permanent damage to the lungs and makes it very hard to breathe. Current treatments can help but don't fully restore lung function. Researchers are testing this new implant to see if it offers a better way to help patients breathe easier and improve their quality of life.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive one or more of the new implants placed in your lungs during a procedure at one of the study hospitals. The study will take place at sites across the United States, Netherlands, Germany, and Brazil. You will have follow-up visits and tests to monitor how well the implant is working and to check for any side effects over time.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Sponsor
Pulmair Medical, Inc.
Enrollment target
~60 participants
Started
March 2026
Primary completion
July 2027
Age range
22 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
VP Clincal Operations
Beth Israel Deaconess Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.